R&D Making a difference for traumatic brain injury patients TBI is the leading cause of death and disability in young adults in the developed world.
R&D The transformation of brain implants Nicolas Vachicouras, CEO of Neurosoft Bioelectronics, tells us how Neurosoft's electrode implant aims to reduce inflammation and scar tissue for patients, provide higher quality brain recor
News FDA fast-tracks NeuroVive's traumatic brain injury drug The FDA has fast-tracked a drug to treat severe traumatic brain injury from Swedish pharma NeuroVive, hastening its development and review.
News Vasopharm drug could limit damage caused by brain injuries German biotech moves into phase 3 after a long wait
R&D Precision, speed, impact: Evolving mass spectrometry for med... MOBILion's Melissa Sherman explores the evolving role of mass spectrometry in drug discovery, complex molecule analysis, and medical research.
Market Access The value of a partner, globally and locally A new podcast looks at recent trends related to drug approvals, as well as challenges and opportunities both small and large pharma companies face
